Polyrizon Ltd. (PLRZ)
NASDAQ: PLRZ · Real-Time Price · USD
0.8151
-0.0313 (-3.70%)
Jun 6, 2025, 2:59 PM - Market open
Polyrizon Employees
As of December 31, 2024, Polyrizon had 6 total employees, including 2 full-time and 4 part-time employees.
Employees
6
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$267,500
Market Cap
22.19K
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
PLRZ News
- 13 days ago - Polyrizon Announces Receipt of Nasdaq Delisting Notice - GlobeNewsWire
- 16 days ago - Polyrizon Emerges with Positive Preclinical Data on Nasal Protection Platform - GlobeNewsWire
- 24 days ago - Polyrizon Targets $3.15B Epilepsy Market with Preclinical Studies for Innovative Rescue Treatment - GlobeNewsWire
- 6 weeks ago - Polyrizon Reports Successful Safety Study of a Formulation of PL-14 Allergy Blocker in Human Nasal Tissue Model - GlobeNewsWire
- 7 weeks ago - Polyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements - GlobeNewsWire
- 2 months ago - Polyrizon Engages Leading Branding Firm for Strategic Brand Development - GlobeNewsWire
- 2 months ago - Polyrizon Ltd. Announces Closing of $17.0 Million Private Placement - GlobeNewsWire
- 2 months ago - Polyrizon Ltd. Announces $17.0 Million Private Placement - GlobeNewsWire